Approvals/TGA/NORALIN Noradrenaline (norepinephrine) (as acid tartrate monohydrate) 3 mg/50 mL solution for intravenous infusion, vial

Approved

STANDARD

NORALIN Noradrenaline (norepinephrine) (as acid tartrate monohydrate) 3 mg/50 mL solution for intravenous infusion, vial

Boucher & Muir Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3fc7c86844d4f902
Product Name: NORALIN Noradrenaline (norepinephrine) (as acid tartrate monohydrate) 3 mg/50 mL solution for intravenous infusion, vial
Artg Id: 316838
Artg Name: NORALIN Noradrenaline (norepinephrine) (as acid tartrate monohydrate) 3 mg/50 mL solution for intravenous infusion, vial
Sponsor: Boucher & Muir Pty Ltd
Company Detail Path: /organization/boucher-and-muir-pty-ltd
Artg Date: 2020-04-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/5f84d127d499a50860a4563eb3743160.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/a39f41eb5798f75b905d182cb04b995c.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

3fc7c86844d4f902

Type

Standard